BlossomHill Therapeutics, Inc.
BLSM
$16.18
-$0.17-1.04%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -21.01M | -10.48M | |||
| Total Depreciation and Amortization | 125.00K | 85.00K | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 648.00K | 410.00K | |||
| Change in Net Operating Assets | -705.00K | -996.00K | |||
| Cash from Operations | -20.94M | -10.98M | |||
| Capital Expenditure | -13.00K | -402.00K | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -13.00K | -402.00K | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 274.00K | 39.00K | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | 274.00K | 39.00K | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -20.68M | -11.34M | |||